Europe represents the second-largest regional market for Aicardi syndrome diagnosis and treatment, characterized by sophisticated healthcare systems, extensive research networks, and progressive rare disease policies. The European market demonstrates remarkable diversity across countries while benefiting from coordinated approaches through European Union frameworks and pan-European rare...